natgillin/translations-raw huggingface dataset:
Disorders of the digestive system and mouth such as constipation, nausea, indigestion, pancreas inflammation, intestinal disorders including bleeding, inflammation of the stomach, liver problems, inflammation of the colon, loss of appetite, flatulence and mouth ulcers.
79 Bolezni prebavil: zaprtje, slabost, dispepsija, vnetje trebušne slinavke, bolezni črevesja, vključno s krvavitvami, vnetje želodčne sluznice, motnje jetrnega delovanja, vnetje debelega črevesa, izguba apetita, napenjanje in ustne razjede.
Disorders of the nerves and senses such as convulsions, tremor, depression, drowsiness, numbness, muscle spasms, changes in thinking or mood.
Bolezni živčevja in čutil konvulzije, tremor, omotica, depresija, dremavost, otopelost, mišični krči, spremembe v načinu mišljenja ali razpoloženja.
Metabolic, blood and vascular disorders such as dehydration, weight loss, high blood sugar, bleeding, clots and bruises, change in blood pressure and abnormal heart beat may be seen.
Presnovne motnje, žilne bolezni in bolezni krvi dehidracija, izguba telesne mase, visok krvni sladkor, krvavitve, strdki in modrice, spremembe krvnega pritiska, nenormalen srčni utrip.
Other unwanted effects caused by the intravenous infusion include local inflammation of the veins.
Drugi neželeni učinek, ki ga je povzročila intravenska infuzija, je lokalno vnetje ven.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet during your treatment with CellCept, please tell your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek med jemanjem zdravila CellCept, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Do not use the powder for solution for infusion after the expiry date stated on the carton and on the vials (EXP).
Praška za koncentrat za raztopino za infundiranje ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na vialah (Uporabno do).
Powder for concentrate for solution for infusion: do not store above 30 °C.
Prašek za koncentrat za raztopino za infundiranje: shranjujte pri temperaturi do 30 °C.
Reconstituted solution and the diluted solution: store at 15 – 30 °C.
Pripravljena raztopina in razredčena raztopina: shranjujte pri temperaturi med 15 °C in 30 °C.
Polysorbate 80 citric acid hydrochloric acid sodium chloride.
CellCept 500 mg prašek za koncentrat za raztopino za infundiranje: polisorbat 80 citronska kislina klorovodikova kislina natrijev klorid
80 Powder for concentrate for solution for infusion:
Prašek za koncentrat za raztopino za infundiranje:
CellCept 500 mg powder for concentrate for solution for infusion must be reconstituted and further diluted with glucose intravenous infusion 5% prior to administration to the patient.
Pred dajanjem bolniku se mora zdravilo CellCept 500 mg prašek za koncentrat za raztopino za infundiranje najprej rekonstruirati in nato razredčiti z intravensko infuzijo 5% glukoze.
Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom
80 Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW Velika Britanija
Ísland Roche a/ s c/ o Icepharma hf Sími: +354 540 8000
81 Ísland Roche a/ s c/ o Icepharma hf Sími: +354 540 8000
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/. >
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
82 PACKAGE LEAFLET:
82 NAVODILO ZA UPORABO
CellCept 1 g/ 5 ml powder for oral suspension mycophenolate mofetil
CellCept 1 g/ 5 ml prašek za peroralno suspenzijo mofetilmikofenolat
if their symptoms are the same as yours
škodovalo, čeprav imajo znake bolezni, podobne vašim.
CellCept 1 g/ 5 ml powder for oral suspension is used to prevent your body rejecting a transplanted kidney, heart or liver.
Z zdravilom CellCept 1 g/ 5 ml prašek za peroralno suspenzijo vašemu telesu preprečimo zavrnitev ledvičnega, srčnega ali jetrnega presadka.
CellCept 1 g/ 5 ml powder for oral suspension is used together with other medicines known as ciclosporin and corticosteroids.
Zdravilo CellCept 1 g/ 5 ml prašek za peroralno suspenzijo uporabljamo skupaj z drugimi zdravili, ki jih imenujemo ciklosporin in kortikosteroidi.
- In case of any evidence of infection (e. g. fever, sore throat), unexpected bruising and/ or
- če opazite znake okužbe (npr. povišana telesna temperatura, vneto grlo), nepričakovane
- If you have or ever have had any problems with your digestive system, e. g. stomach ulcers.
- imate ali ste kdaj imeli težave s prebavili, npr. rano na želodcu.
- If you suffer from phenylketonuria (a rare, hereditary disorder of the metabolism).
Ker zdravilo CellCept zmanjša obrambno sposobnost vašega organizma, obstaja zvečana možnost nastanka kožnega raka, zato se je treba izogibati sončni svetlobi in UV- žarkom z uporabo zaščitnih oblačil in sončne kreme z visokim zaščitnim faktorjem.
CellCept reduces your body’ s defence mechanism.
Jemanje drugih zdravil:
Therefore you should limit your exposure to sunlight and UV light by wearing appropriate protective clothing and using a sunscreen with a high protection factor.
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Please inform your doctor or pharmacist if you are taking, or have recently taken, any other medicines, even those not prescribed.
83 Če na katero od spodaj naštetih vprašanj odgovorite pritrdilno, se pred jemanjem zdravila CellCept posvetujte s svojim zdravnikom.
If you answer yes to any of the following questions talk to your doctor before you start to take CellCept:
- Ali morda jemljete zdravila, ki vsebujejo azatioprin ali druga imunosupresivna zdravila (bolniki
(which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high blood cholesterol), rifampicin (antibiotic), antacids, phosphate binders (used in patients with chronic renal failure to reduce the absorption of phosphate) or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
jih včasih prejmejo po presaditveni operaciji), holestiramin (uporabljajo ga za zdravljenje bolnikov z visokim holesterolom), rifampicin (antibiotik), antacide, fosfatne vezalce (uporabljajo jih za zmanjšanje vezave fosfatov pri bolnikih s kronično ledvično odpovedjo) ali druga zdravila (vključno s tistimi, ki ste jih dobili brez recepta), za katera vaš zdravnik ne ve?
Your doctor should advise you about using contraception before taking CellCept, whilst taking CellCept, and for six weeks after you have stopped taking CellCept.
Zdravnik vam bo svetoval glede uporabe kontracepcijske zaščite pred in med jemanjem zdravila CellCept in šest tednov po prekinitvi jemanja zdravila CellCept.
Important information about some of the ingredients of CellCept 1 g/ 5 ml powder for oral suspension:
Pomembne informacije o nekaterih sestavinah zdravila CellCept 1 g/ 5 ml prašek za peroralno suspenzijo:
If you suffer from phenylketonuria (a rare, hereditary disorder of the metabolism), talk to your doctor before you start to take this medicine.
Če imate fenilketonurijo (redka, dedna motnja presnove) se pred jemanjem tega zdravila posvetujte s svojim zdravnikom.
This medicine also contains sorbitol which is a sugar.
To zdravilo vsebuje tudi sorbitol, ki je vrsta sladkorja.
If you have been told by your doctor that you have an intolerance to some sugars, such as sorbitol, contact your doctor before taking this medicinal product.
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila posvetujte s svojim zdravnikom.
The usual way to take CellCept oral suspension is as follows:
Običajen način jemanja peroralne suspenzije zdravila CellCept je naslednji:
The recommended daily dose is 10 ml suspension (2 g of the active ingredient) taken as 2 separate doses.
Priporočeni dnevni odmerek je 10 ml suspenzije (2 g zdravilne učinkovine), zaužitih kot dva posamezna odmerka.
This means taking 5 ml suspension in the morning and then 5 ml suspension in the evening.
5 ml suspenzije vzemite zjutraj, 5 ml pa zvečer.
84 The dose given will vary depending on the size of the child.
Dani odmerek bo odvisen od velikosti otroka.
The recommended dose is 600 mg/ m² taken twice a day.
Priporočeni odmerek je 600 mg/ m2 dvakrat na dan.
The first dose will be given within 5 days following the transplant operation.
Priporočeni dnevni odmerek
The recommended daily dose is 15 ml suspension (3 g of the active ingredient) taken as 2 separate doses.
84 je 15 ml suspenzije (3 g zdravilne učinkovine), razdeljenih na dva posamezna odmerka.
This means taking 7.5 ml suspension in the morning then 7.5 ml suspension in the evening.
7, 5 ml suspenzije vzemite zjutraj, 7, 5 ml pa zvečer.
No data are available to recommend the use of CellCept in children who have received a heart transplant.
Podatki o priporočenem odmerjanju pri bolnikih, ki so prejeli srčni presadek, niso na voljo.
The recommended daily dose is 15 ml suspension (3 g of the active ingredient) taken as 2 separate doses.
Priporočeni dnevni odmerek je 15 ml suspenzije (3 g zdravilne učinkovine), razdeljenih na dva posamezna odmerka.
It is recommended that the pharmacist reconstitutes CellCept oral suspension for you prior to dispensing.
Priporočamo, da peroralno suspenzijo pred izdajo zdravila CellCept pripravi farmacevt.
To reconstitute the suspension the pharmacist will proceed as follows:
Farmacevt bo suspenzijo pripravil po naslednjih navodilih:
(The shelf-life of the reconstituted suspension is 2 months.)
(Rok uporabnosti pripravljene suspenzije je dva meseca.)
Avoid inhalation or direct contact with skin or mucous membranes of the dry powder as well as direct contact of the reconstituted suspension with the skin.
Izogibajte se vdihavanju ali neposrednemu stiku praška s kožo ali sluznicami, prav tako se izogibajte neposrednemu stiku že pripravljene suspenzije s kožo.
If such contact occurs, wash thoroughly with soap and water; rinse eyes with plain water.
Če pride do stika, dobro sperite površino z milom in vodo, oči sperite le z vodo.
85 To withdraw the suspension with the oral dispenser proceed as follows:
Za odvzem suspenzije s peroralnim razdelilnikom ravnajte po naslednjih navodilih:
Shake closed bottle well for about 5 seconds before each use.
dobro stresajte približno 5 sekund.
Remove child-resistant cap.
Snemite za otroke varno zaporko.
Before inserting the tip of the dispenser into bottle adapter, push the plunger completely down toward the tip of the dispenser.
Preden vstavite vrh razdelilnika v nastavek za steklenico, potisnite bat popolnoma do konca proti vrhu razdelilnika.
Insert tip firmly into opening of the bottle adapter.
V odprtino nastavka za steklenico trdno pritrdite vrh razdelilnika.
Pull the plunger out slowly until the desired amount of medication is withdrawn into the dispenser (see figure).
Počasi izvlecite bat, dokler v razdelilnik ne zajamete želene količine zdravila (glejte sliko).
Dispense directly into mouth and swallow.
Zdravilo dajte direktno v usta in pogoltnite.
Do not mix with any liquid prior to dispensing.
Pred dajanjem zdravila ne mešajte z drugimi tekočinami.
Immediately after administration:
Po vsaki uporabi zaprite steklenico z za otroke varno zaporko.
Disassemble dispenser, rinse under running tap water and air dry prior to next use.
Takoj po dajanju zdravila: razdelilnik razstavite, ga sperite pod tekočo vodo in posušite na zraku pred naslednjo uporabo.
Care should be taken to avoid contact of the skin with the suspension.
Pazite, da ne pride do stika suspenzije s kožo.
If such contact occurs, wash thoroughly with soap and water.
Če pride do stika, kožo dobro umijte z milom in vodo.
If you take more suspension than you have been told to take, or if someone else accidentally takes your medicine, immediately see a doctor or go to a hospital straight away.
Če ste zaužili več suspenzije, kot vam je bilo predpisano, ali če nekdo drug po nesreči zaužije vaše zdravilo, takoj poiščite zdravnika ali pojdite v bolnišnico.
86 If you stop taking CellCept:
Če ste prenehali jemati zdravilo CellCept:
CellCept reduces your body’ s own defence mechanisms to stop you rejecting your transplanted kidney, heart or liver.
Zdravilo CellCept zmanjša obrambno sposobnost vašega organizma, da bi preprečil zavrnitev ledvičnega, srčnega ali jetrnega presadka, zato se vaš organizem ne bo sposoben ubraniti okužb, kot bi
Consequently your body will not be as good as normal at fighting infections.
86 se sicer.
Disorders of the skin such as acne, cold sores, shingles, skin growth, hair loss, rash, itching.
Bolezni kože in podkožja akne, herpes febrilis, pasasti izpuščaj, rast kože, izguba las, izpuščaj, srbenje.
Disorders of the nerves and senses such as convulsions, tremor, dizziness, depression, drowsiness, numbness, muscle spasms, anxiety, changes in thinking or mood.
Bolezni živčevja in čutil konvulzije, tremor, omotica, depresija, dremavost, otopelost, mišični krči, spremembe v načinu mišljenja ali razpoloženja.
Metabolic, blood and vascular disorders such as weight loss, gout, high blood sugar, bleeding, clots and bruises, change in blood pressure, abnormal heart beat and dilation of blood vessels may be seen.
Presnovne motnje, žilne bolezni in bolezni krvi dehidracija, izguba telesne mase, visok krvni sladkor, krvavitve, strdki in modrice, spremembe krvnega pritiska, nenormalen srčni utrip.
Do not use after the expiry date stated on the carton and bottle label (EXP).
Praška za peroralno suspenzijo ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na nalepki stekleničke (Uporabno do).
87 The shelf-life of the reconstituted suspension is two months.
Rok uporabnosti pripravljene suspenzije je 2 meseca.
The pharmacist will write the date of expiration on the bottle label in the black box next to "Use before".
Farmacevt bo rok uporabnosti suspenzije napisal na nalepko stekleničke v črno polje poleg “ Uporabno do ”.
Powder for oral suspension: do not store above 30°C.
Prašek za peroralno suspenzijo: shranjujte pri temperaturi do 30 °C.
Reconstituted suspension: do not store above 30°C.
Pripravljena suspenzija: shranjujte pri temperaturi do 30 °C.
- The active substance is mycophenolate mofetil
- Zdravilna učinkovina je mofetilmikofenolat.
CellCept 1 g/ 5 ml powder for oral suspension: sorbitol silica, colloidal anhydrous sodium citrate soybean lecithin mixed fruit flavour xanthan gum aspartame* (E951) methyl parahydroxybenzoate (E218) citric acid anhydrous
CellCept 1 g/ 5 ml prašek za peroralno suspenzijo: sorbitol brezvoden koloidni silicijev dioksid natrijev citrat sojin lecitin mešana sadna aroma ksantanski gumi aspartam * (E951) metilparahidroksibenzoat (E218) brezvodna citronska kislina
CellCept 1 g/ 5 ml powder for oral suspension:
CellCept 1 g/ 5 ml prašek za peroralno suspenzijo:
Deutschland Roche Pharma AG Tel: +49 (0) 7624 140
88 Deutschland Roche Pharma AG Tel: +49 (0) 7624 140
Tel: +39 - 039 2471
Tel: +39 - 039 2471 Kύπρος Γ. Α. Σταμάτης & Σια Λτδ.
Sverige Roche AB Tel: +46 (0) 8 726 1200
Suomi/ Finland Roche Oy Puh/ Tel: +358 (0) 10 554 500 Sverige Roche AB Tel: +46 (0) 8 726 1200
This leaflet was last approved on {MM/ YYYY}
Navodilo je bilo odobreno {MM/ LLLL}
CellCept 500 mg tablets mycophenolate mofetil
CellCept 500 mg tablete mofetilmikofenolat
CellCept tablets are used to prevent your body rejecting a transplanted kidney, heart or liver.
S tabletami zdravila CellCept vašemu telesu preprečimo zavrnitev ledvičnega, srčnega ali jetrnega presadka.
91 If you answer yes to any of the following questions talk to your doctor before you start to take CellCept:
90 Če na katero od spodaj naštetih vprašanj odgovorite pritrdilno, se pred jemanjem zdravila CellCept posvetujte s svojim zdravnikom.
(which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high cholesterol), rifampicin (antibiotic), antacids, phosphate binders (used in patients with chronic renal failure to reduce the absorption of phosphate) or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
jih včasih prejmejo po presaditveni operaciji), holestiramin (uporabljajo ga za zdravljenje bolnikov z visokim holesterolom), rifampicin (antibiotik), antacide, fosfatne vezalce (uporabljajo jih za zmanjšanje vezave fosfatov pri bolnikih s kronično ledvično odpovedjo) ali druga zdravila (vključno s tistimi, ki ste jih dobili brez recepta), za katera vaš zdravnik ne ve?
The recommended daily dose is 4 tablets (2 g of the active ingredient) taken as 2 separate doses.
Priporočeni dnevni odmerek je 4 tablete (2 g zdravilne učinkovine), zaužite kot 2 posamezna odmerka.
This means taking 2 tablets in the morning then 2 tablets in the evening.
2 tableti vzemite zjutraj, 2 pa zvečer.
The recommended daily dose is 6 tablets (3 g of the active ingredient) taken as 2 separate doses.
Priporočeni dnevni odmerek je 6 tablet (3 g zdravilne učinkovine), razdeljenih na 2 posamezna odmerka.
This means taking 3 tablets in the morning then 3 tablets in the evening.
3 tablete vzemite zjutraj, 3 pa zvečer.
92 Liver Transplant
Presaditev jeter
Adults:
91 Odrasli:
This means taking 3 tablets in the morning and then 3 tablets in the evening.
3 tablete vzemite zjutraj, 3 pa zvečer.
If you take more tablets than you have been told to take, or if someone else accidentally takes your medicine, immediately see a doctor or go to a hospital straight away.
Če ste zaužili več tablet, kot vam je bilo predpisano, ali če nekdo drug po nesreči zaužije vaše zdravilo, takoj poiščite zdravnika ali pojdite v bolnišnico.
93 Other unwanted effects may include:
Drugi neželeni učinki:
Disorders of the digestive system and mouth such as constipation, nausea, indigestion, pancreas inflammation, intestinal disorders including bleeding, inflammation of the stomach, liver problems, inflammation of the colon, loss of appetite, flatulence and mouth ulcers.
92 Bolezni prebavil zaprtje, slabost, dispepsija, vnetje trebušne slinavke, bolezni črevesja, vključno s krvavitvami, vnetje želodčne sluznice, motnje jetrnega delovanja, vnetje debelega črevesa, izguba apetita, napenjanje in ustne razjede.
Disorders of the lungs such as pneumonia, bronchitis, shortness of breath, cough, fluid on the lungs/ chest cavity, sinus problems.
Bolezni dihal pljučnica, bronhitis, dispneja, kašelj, tekočina v prsih in prsni votlini, težave s sinusi.
Do not use the tablets after the expiry date stated on the carton (EXP).
Zdravila CellCept ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli (Uporabno do).
Tablet coating: hydroxypropyl methylcellulose hydroxypropyl cellulose titanium dioxide (E171) polyethylene glycol 400 indigo carmine aluminium lake (E132) red iron oxide (E172)
Obloga tablet: hipromeloza hidroksipropilceluloza titanov dioksid (E171) makrogol 400 indigotin (E132) rdeči železov oksid (E172)
94 What CellCept looks like and contents of the pack
Izgled zdravila CellCept in vsebina pakiranja
Tablets:
93 Tablete:
CellCept tablets: lavender coloured caplet-shaped tablet, engraved with "CellCept 500" on one side and "Company logo" on the other.
CellCept tablete: svetlo vijoličaste barve, ovalne oblike, z vgraviranim napisom “ CellCept 500 ” na eni strani in logom podjetja na drugi.
Ireland Roche Products (Ireland) Ltd.
94 Ireland Roche Products (Ireland) Ltd.
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu.
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
It explains how the Committee for Medicinal products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil opravljene študiej, na podlagi katerih je oblikoval priporočila glede uporabe zdravila.
What is CELSENTRI?
Kaj je zdravilo CELSENTRI?
CELSENTRI is a medicine containing the active substance maraviroc.
CELSENTRI je zdravilo, ki vsebuje zdravilno učinkovino maravirok.
What is CELSENTRI used for?
Za kaj se zdravilo CELSENTRI uporablja?
CELSENTRI is an antiviral medicine.
CELSENTRI je protivirusno zdravilo.
It is used in combination with other antiviral medicines to treat adults who are infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Uporablja se v kombinaciji z drugimi protivirusnimi zdravili za zdravljenje odraslih, okuženih z virusom humane imunske pomanjkljivosti tipa 1 (HIV- 1), virusom, ki povzroča sindrom pridobljene imunske pomanjkljivosti (AIDS).
CELSENTRI is only used in patients who have been treated for HIV infection before and only when the HIV-1 they are infected with is ‘ CCR5-tropic’, which is determined by a blood test.
Zdravilo CELSENTRI se uporablja samo pri bolnikih, ki so se predhodno zdravili zaradi okužbe s HIV, in samo v primerih, ko so okuženi s „ CCR5 tropnim “ virusom HIV- 1, kar se ugotovi s krvnim testom.
This means that the virus, when infecting a cell, attaches to a specific protein called CCR5 on the surface of the cell.
To pomeni, da se virus, ko okuži celico, veže na specifično beljakovino CCR5 na površini celice.
How is CELSENTRI used?
Kako se zdravilo CELSENTRI uporablja?
Treatment with CELSENTRI should be initiated by a doctor who has experience in the management of HIV infection.
Zdravljenje z zdravilom CELSENTRI mora uvesti zdravnik z izkušnjami z zdravljenjem okužb z virusom HIV.
Before treatment, the doctor must check that the patient ’ s blood only shows infection with CCR5-tropic virus, using a newly drawn blood sample and a reliable ‘ tropism test’.
Pred zdravljenjem mora zdravnik na svežem vzorcu krvi in z zanesljivim „ testom tropizma “ preveriti, ali je bolnikova kri okužena samo s CCR5- tropnim virusom.
The recommended dose is 150, 300 or 600 mg twice a day, depending on the other medicines that the patient is taking.
Priporočen odmerek je 150, 300 ali 600 mg dvakrat dnevno, odvisno od tega, katera druga zdravila bolnik jemlje.
CELSENTRI should be used with caution in patients aged over 65 years and in patients who have problems with their liver.
Pri bolnikih, starejših od 65 let, in pri bolnikih, ki imajo težave z jetri, je treba zdravilo CELSENTRI uporabljati previdno.
Patients who have kidney problems may need to take CELSENTRI less frequently if they are taking other medicines that are broken down in the body (metabolised) in the same way as CELSENTRI, and their response to treatment should be closely monitored.
Bolniki, ki imajo težave z ledvicami, bodo morda morali zdravilo CELSENTRI jemati manj pogosto, če jemljejo druga zdravila, ki se v telesu razgrajujejo (presnavljajo) na enak način kot zdravilo CELSENTRI, poleg tega pa je treba skrbno spremljati njihov odziv na zdravljenje.
For more information, see the Summary of Product Characteristics (also part of the EPAR).
Več informacij najdete v Povzetku glavnih značilnosti zdravila (prav tako del EPAR).
There is no information on switching to CELSENTRI from another type of medicine for HIV infection in patients whose HIV is being treated successfully, when no virus can be detected in their blood.
Informacije o prehodu na zdravilo CELSENTRI z druge vrste zdravila za zdravljenje okužbe s HIV pri bolnikih, pri katerih je HIV uspešno zdravljen, ko v njihovi krvi ni mogoče odkriti virusa, niso na voljo.
There is also no information on the re-use of CELSENTRI in patients who have taken it in the past, but in whom it stopped working.
Prav tako ni informacij o ponovni uporabi zdravila CELSENTRI pri bolnikih, ki so ga jemali v preteklosti, vendar je pri njih prenehalo učinkovati.
Other treatments should be considered in these cases.
V takšnih primerih je potrebno razmisliti o drugih možnostih zdravljenja.